Physician profile
Kathryn Ryan
NPI 1447884085
$466.23
in general payments reported to CMS, 2019-2025
12 companies · $75.26 in 2025
The $75.26 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $34.80 · 2022: $76.63 · 2023: $110 · 2024: $170 · 2025: $75.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $354.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $116.25 | 2023-2024 | Airsupra, Farxiga |
| Novo Nordisk INC | $64.86 | 2021-2024 | Wegovy, Ozempic, Rybelsus |
| Exact Sciences Corporation | $55.14 | 2023-2025 | Cologuard Collection Kit |
| Abbvie INC. | $51.30 | 2022-2023 | |
| Glaxosmithkline, LLC. | $45.64 | 2023-2024 | Shingrix |
| Lilly USA, LLC | $29.70 | 2022-2024 | Mounjaro |
| Alk-Abello, INC | $19.31 | 2025 | Ragwitek, Odactra, Grastek |
| Amarin Pharma, INC. | $18.39 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.00 | 2022 | |
| Kyowa Kirin, INC. | $16.97 | 2024 | Crysvita |
| Sanofi-Aventis U.S. LLC | $15.72 | 2022 | |
| Cranial Technologies, INC | $14.95 | 2025 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Ryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.